Jennifer C Petter

Title: Innovations and Contributions of Inventor Jennifer C. Petter

Introduction

Jennifer C. Petter is a prominent inventor based in Stow, MA (US). She has made significant contributions to the field of biochemistry and pharmaceuticals, holding a total of 3 patents. Her work focuses on developing innovative compounds and methods that have the potential to impact drug discovery and treatment.

Latest Patents

One of her latest patents is titled "Nucleic acid-binding photoprobes and uses thereof." This invention relates to photoactivatable compounds and methods for determining binding sites and structural information about RNA transcripts. It also provides methods for identifying RNA transcripts that bind to compounds, making them druggable, as well as methods for screening drug candidates and determining drug binding sites on target RNA.

Another significant patent is "Isoxazole carboxamides as irreversible SMYD inhibitors." This disclosure presents substituted isoxazole carboxamides and their pharmaceutically acceptable salts and solvates. The compounds are designed to treat disorders responsive to the blockade of SMYD proteins, such as SMYD3 or SMYD2, and are particularly useful in cancer treatment.

Career Highlights

Throughout her career, Jennifer has worked with notable companies, including Epizyme, Inc. and Arrakis Therapeutics, Inc. Her expertise in the field has allowed her to contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Jennifer has collaborated with esteemed colleagues, including Richard Chesworth and Megan Alene Cloonan Foley. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Jennifer C. Petter is a distinguished inventor whose work in biochemistry and pharmaceuticals has led to valuable innovations. Her patents reflect her commitment to advancing drug discovery and treatment methodologies.